Medically Reviewed By Dr. Meghav Shah Updated on November 28, 2024
Hypertrophic cardiomyopathy (HCM) ablation is done in select cases to reduce the septal thickening by intentionally causing a localised ischemia in the septal area, i.e. there is an induced heart attack to that area to shrink its size. This procedure is done percutaneously through the groin arteries.
The patient is shifted to the ICU to monitor the heart rhythm as the procedure can be prone for abnormal ECG tracing in the form of heart block or ventricular tachycardia. The patient is expected to lie flat for a few hours post procedure to prevent any complication at the groin site.
Also, an echocardiogram is done prior to discharge to assess the septal size, gradients across it and to rule out a ventricular septal defect (procedure induced). If no symptoms, the patient can be discharged a couple of days post procedure.
Follow-up and Monitoring
Long term follow-up is essential as these patients have to be regularly monitored annually or bi annually to adjust medicines and assess gradients and septal size on the echocardiogram.
Procedure is usually successful in more than ¾ of the cases. Post successful procedure, patients may experience considerable relief in symptoms with improvement in the quality of life.
Risks associated with the procedure are:
Deciding open heart surgery v/s catheter directed alcohol ablation is paramount, as both procedures are associated with varied risks and benefits. Do consult your cardiologist for a detailed understanding of both the procedures to help you decide if they are necessary and if yes, which option will be better for you.